The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 29, 2017

Filed:

Aug. 17, 2016
Applicant:

Novartis Ag, Basel, CH;

Inventors:

Michael Hartman, Millbrae, CA (US);

Thomas E Tarara, Burlingame, CA (US);

Patrick Teung, Sunnyvale, CA (US);

Jeffry G Weers, Belmont, CA (US);

Assignee:

Novartis AG, Basel, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/58 (2006.01); A61K 9/16 (2006.01); A61K 45/06 (2006.01); A61K 47/02 (2006.01); A61K 9/00 (2006.01); A61K 47/24 (2006.01); A61K 9/14 (2006.01); A61K 31/40 (2006.01); A61K 31/4704 (2006.01);
U.S. Cl.
CPC ...
A61K 31/58 (2013.01); A61K 9/0075 (2013.01); A61K 9/145 (2013.01); A61K 9/1611 (2013.01); A61K 9/1617 (2013.01); A61K 9/1682 (2013.01); A61K 31/40 (2013.01); A61K 31/4704 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/24 (2013.01); Y10S 514/826 (2013.01);
Abstract

Embodiments of the present invention provide a dry powder composition comprising porous carrier particles associated with one, two, three or more micronized drugs or APIs wherein an ordered mixture between the micronized drug or drugs and the carrier particle results, such that the micronized drug or drugs adhere strongly to the carrier particles forming a stable ordered mixture of respirable agglomerates. Embodiments of the present invention further comprise a spray-drying process to create the respirable agglomerates. Embodiments of the present invention further relate to the use of the dry powder formulation comprising respirable agglomerates for the treatment of a patient having a disease or condition which is treatable thereby.


Find Patent Forward Citations

Loading…